Nutex Health Inc. (NUTX) Market Cap & Valuation Ratios
Nutex Health Inc. (NUTX) has a market cap of $1.4B, a trailing P/E of 8.2 and a price-to-sales ratio of 1.7, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NUTXNutex Health Inc.Follow NUTX — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- 8.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Peers
medical care facilities · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| NUTX | 1.4 | 8.2 | 1.5 | 3.3 | 19.1% | +7% | 43% | 139% |
| ASTH | 2.1 | 45.1 | 0.7 | 16.0 | 4.5% | +59% | 3% | 6% |
| SGRY | 2.1 | — | 1.7 | 10.0 | 9.1% | +4% | 11% | 6% |
| AMN | 1.9 | 17.8 | 0.7 | 6.5 | 23.6% | +24% | 6% | 10% |
| ARDT | 1.7 | 22.3 | 0.3 | 5.7 | 17.6% | +3% | 3% | 9% |
| HCSG | 1.7 | 17.1 | 0.8 | 10.6 | 6.3% | +4% | 7% | 28% |
| SNDA | 1.6 | — | 6.0 | 126.6 | -4.2% | +49% | -13% | -4% |
| AGL | 1.5 | — | 0.2 | — | -5.6% | +0.3% | -5% | -146% |
| PNTG | 1.5 | 46.0 | 1.5 | 22.7 | 2.4% | +38% | 6% | 8% |
| USPH | 1.3 | — | 1.9 | 15.3 | 4.8% | +11% | 9% | 9% |
| INNV | 1.3 | — | 1.2 | 50.9 | 3.9% | +16% | 0.3% | 1.0% |
| Median of these 10 | 22.3 | 1.0 | 15.3 | 4.7% | +14% | 4% | 7% |
P/E 8.2 vs. a peer median of 22.3; EV/Sales 1.5 vs. 1.0. NUTX's own P/E sits at the 28th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesSGRY and SNDA and AGL and USPH and INNV have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Nutex Health Inc. — questions
- What is Nutex Health Inc.'s market cap?
- $1.4B.
- What is Nutex Health Inc.'s P/E ratio?
- 8.2 on trailing twelve-month earnings to 2026-06-30.
- What is Nutex Health Inc.'s price-to-sales ratio?
- 1.7.
Every figure on this page comes from Nutex Health Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.